NCT03022409 2021-08-10A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).AstraZenecaPhase 1 Completed21 enrolled